Cervix carcinoma

• A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a … Pending
  2025-523590-42-00 7 "Locally Advanced or Metastatic Solid Tumors"
• Phase 2 Pan-Tumor Trial of R-DXd for Advanced/Metastatic Solid Tumors Recruitment ended
  2024-513307-13-00 4 2025-05-26 "Advanced/metastatic solid tumors including gynecological can"
• Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended
  2022-502867-39-00 1 2023-09-29 "Advanced solid tumors including non-small cell lung cancer ("
• A Randomized, Open-Label Trial to Compare Tisotumab Vedotin to Investigator's Choice Chemotherapy in Patients with Cervical Cancer Ended
  2023-503813-31-01 5 2021-09-17 "Second- or Third-Line Recurrent or Metastatic Cervical Cance"
• Efficacy and safety of tisotumab vedotin (HuMax®-TF-ADC) monotherapy and in combination in recurrent or Stage IVB cervical cancer Ended
  2023-508832-68-00 9 2019-03-28 "Recurrent or stage IVB cervical cancer"
• Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Chemotherapy plus Paclitaxel and Bevacizumab in Carcinoma of the Cervi … Ended
  2024-514179-17-00 5 2018-10-02 "Metastatic (stage IVB), Persistent, or Recurrent Carcinoma o"

Showing 1–6 of 6 trials